Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedResults have been posted, including the number of participants with response and toxicity data, along with associated results submission dates. A PDF of the Study Protocol and Statistical Analysis Plan has been added under Study Documents.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not all relate to the study. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe banner about a lapse in government funding that previously appeared on the page has been removed, which does not affect the study information displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page content appears unchanged; the Study Details page for NCT02437071 and its sections (Overview, Eligibility Criteria, Study Plan, and Interventions) remain the same.SummaryDifference0.4%

- Check71 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.